MedTrace Logo

Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial

NCT00520338 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-11-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether celecoxib is effective in the treatment postoperative pain after thyroidectomy.

The research hypothesis:

There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib or placebo.

Conditions

  • Postoperative Pain
  • Thyroidectomy
  • Cyclooxygenase 2 Inhibitors

Interventions

DRUG

celecoxib

1. placebo 2. celecoxib 400 mg oral single dose

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Sirilak Suksompong, MD · Department of anesthesiology. Siriraj Hospital, Mahidol University, Bangkok, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00520338 on ClinicalTrials.gov